# Use of Preemptive Pudendal Nerve Block Prior to Hydrodistention for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)

> **NCT02517996** · NA · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 18 (actual)

## Conditions studied

- Interstitial Cystitis
- Painful Bladder Syndrome

## Interventions

- **DRUG:** Lidocaine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02517996
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-02
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Preliminary results were promising when interim analysis performed but terminated due to primary investigators left recruitment site.
- **Last updated:** 2019-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02517996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02517996, "Use of Preemptive Pudendal Nerve Block Prior to Hydrodistention for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02517996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*